<font color="red">Local_2</font> <font color="red">immunotherapy_2</font> <font color="red">by_1</font> <font color="red">inhalation_1</font> <font color="red">of_1</font> <font color="red">a_1</font> <font color="red">powder_1</font> <font color="red">extract_1</font> in asthma due to <font color="red">house_1</font> <font color="red">dust_1</font> <font color="red">mite_1</font> <font color="red">Dermatophagoides_1</font> <font color="red">pteronyssinus_1</font> <font color="red">:_1</font> a double - blind comparison with <font color="red">parenteral_1</font> <font color="red">immunotherapy_1</font> <font color="red">._1</font> 
<br>
<br> To verify the efficacy and the tolerability of <font color="red">local_2</font> <font color="red">immunotherapy_2</font> <font color="red">(_2</font> <font color="red">LI_2</font> <font color="red">)_2</font> <font color="red">by_2</font> <font color="red">inhalation_2</font> <font color="red">of_2</font> <font color="red">a_2</font> <font color="red">powder_3</font> <font color="red">extract_3</font> <font color="red">of_3</font> <font color="red">house_3</font> <font color="red">dust_3</font> <font color="red">mite_3</font> <font color="red">(_3</font> <font color="red">HDM_3</font> <font color="red">)_3</font> <font color="red">,_3</font> in comparison with <font color="red">parenteral_2</font> <font color="red">immunotherapy_2</font> <font color="red">(_2</font> <font color="red">PI_2</font> <font color="red">)_2</font> <font color="red">by_1</font> <font color="red">injection_1</font> <font color="red">,_1</font> 10 patients with asthma due to HDM were studied in a blind fashion . 5 patients ( Group A ) <font color="red">underwent_1</font> <font color="red">LI_2</font> <font color="red">and_1</font> <font color="red">subcutaneous_1</font> <font color="red">injections_1</font> <font color="red">of_1</font> <font color="red">placebo_6</font> <font color="red">,_6</font> <font color="red">5_2</font> <font color="red">patients_2</font> <font color="red">(_2</font> <font color="red">Group_2</font> <font color="red">B_2</font> <font color="red">)_2</font> <font color="red">underwent_2</font> <font color="red">PI_3</font> <font color="red">and_2</font> <font color="red">inhalation_3</font> <font color="red">of_3</font> <font color="red">lactose_6</font> <font color="red">for_2</font> <font color="red">6_2</font> <font color="red">months_2</font> <font color="red">._2</font> <font color="red">In_1</font> <font color="red">both_1</font> <font color="red">groups_1</font> <font color="red">each_1</font> <font color="red">inhalation_1</font> <font color="red">was_1</font> <font color="red">preceded_1</font> <font color="red">by_1</font> <font color="red">premedication_1</font> <font color="red">with_1</font> <font color="red">disodium_5</font> <font color="red">cromoglycate_5</font> <font color="red">(_4</font> <font color="red">DSCG_4</font> <font color="red">)_4</font> <font color="red">(_1</font> <font color="red">40_1</font> <font color="red">mg_1</font> <font color="red">)_1</font> <font color="red">._1</font> In Group A a significant decrease in symptoms score and in peak expiratory flow ( PEF)-derived parameters was observed already after 3 months of treatment , and 2 patients lost the late component of the bronchial response to the challenge with HDM . No significant variation was found in bronchial responsiveness to methacholine and ultrasonically nebulized distilled water ( UNDW ) and in immunologic humoral and cellular parameters in peripheral blood after treatment in either group . No local important adverse reactions were observed in Group A and no systemic side effects were observed in either group . We conclude that <font color="red">LI_1</font> is as effective as <font color="red">PI_1</font> <font color="red">,_1</font> but more rapid in its action , in the treatment of asthma due to HDM . Moreover , <font color="red">LI_1</font> is locally well tolerated , providing <font color="red">DSCG_1</font> is inhaled before each <font color="red">therapeutic_1</font> <font color="red">inhalation_1</font> <font color="red">,_1</font> and does not induce systemic side effects .